YEARBOOK Medicinal Chemistry in Europe
Total Page:16
File Type:pdf, Size:1020Kb
EFMC YEARBOOK Medicinal Chemistry in Europe EFMC-ISMC 2020 EFMC-YMCS 2020 EFMC-ASMC’19 Basel, Switzerland Basel, Switzerland EFMC-YMCS 2019 September 6-10, 2020 September 10-11, 2020 Special reports EFMC International Symposium on Medicinal Chemistry Basel, CH September 6-10, 2020 SESSIONS AND SESSION COORDINATORS EFMC AWARD LECTURES CHEMICAL BIOLOGY THERAPEUTIC AREAS – The Nauta Pharmacochemistry Award – The UCB-Ehrlich Award for Excellence in Medicinal CARBOHYDRATE RECOGNITION AND DRUG DESIGN ADDRESSING NEGLECTED AND EMERGING VIRAL Chemistry Alexander Titz (Helmholtz Institute for Pharmaceutical DISEASES WITH SMALL MOLECULES AFMC Session – The Prous Institute-Overton and Meyer Award for New Sciences, DE) Esin Aki-Yalçin (Ankara University, TR) Technologies in Drug Discovery CHEMICAL APPROACHES TO STEM CELL BREATHING LIFE INTO INHALED DRUG DISCOVERY: DIFFERENTIATION ICBS Session CHALLENGES AND BREAKTHROUGHS TO THE CLINIC EFMC PARTNER PRIZES Colin Pouton (Monash University, AU) ACSMEDI Session Nicole Goodwin(GSK, US) – The IUPAC-Richter Prize in Medicinal Chemistry CHEMICAL PROBES FOR TARGET DISCOVERY AND – The Klaus Grohe Prize VALIDATION CHEMICAL TOOLS AND DRUG DISCOVERY FOR Gyorgy Keseru (Hungarian Academy of Sciences, HU) NEUROINFLAMMATION EUCHEMS Session EFMC PRIZE LECTURES Sonsoles Martin-Santamaria (Biological Research Center, ES) MOLECULAR IMAGING TOOLS FOR CHEMICAL BIOLOGY Valle Palomo (CIB, ES) NEW STRATEGIES AND AGENTS FOR TARGETING – EFMC Prize for a Young Medicinal Chemist in Industry GRAMNEGATIVE PATHOGENS – EFMC Prize for a Young Medicinal Chemist in Academia PHOTOCHEMISTRY IN DRUG DISCOVERY: Vicky Steadman (Selcia, UK) PHOTOPHARMACOLOGY, PHOTOTOXICITY AND INTERNATIONAL ORGANISING COMMITTEE SYNTHESIS ACSMEDI Session NEXT GENERATION DRUGS FOR HEART FAILURE Timothy Henderson (Merck, Sharp & Dohme, US) Alleyn Plowright (Sanofi, DE) Symposium Chairman Karl-Heinz ALTMANN SMALL MOLECULES TARGETING RNA FUNCTION RECENT ADVANCES IN ANTICANCER DRUG DISCOVERY (ETH Zürich, CH) AND PROCESSING Roberto di Santo (Sapienza University of Rome, IT) Maria Duca (University of Côte d'Azur, FR) Members TARGETING FIBROTIC DISEASES WITH SMALL Marko ANDERLUH TARGET DECONVOLUTION STRATEGIES IN DRUG MOLECULES (University of Ljubljana, SI) DISCOVERY Christian Kuttruff (Boehringer Ingelheim, DE) Yves P. AUBERSON Paul Brennan (University of Oxford, UK) (Novartis, CH) TISSUE AND CELL SPECIFIC DRUG DELIVERY Karl-Heinz BARINGHAUS TECHNOLOGIES EUFEPS Session (Sanofi, DE) Sébastien Papot (University of Poitiers, FR) Werngard CZECHTIZKY APPLICATION OF ARTIFICIAL INTELLIGENCE IN DRUG (AstraZeneca, SE) DISCOVERY PROJECTS OPEN SESSIONS Beatriz DE PASCUALTERESA Christopher Swain (Cambridge MedChem Consulting, UK) (CEU San Pablo University, ES) FIRST TIME DISCLOSURES Luc VAN HIJFTE BIOCATALYSIS & LATE STAGE FUNCTIONALIS ATION (Mercachem-Syncom, NL) Radka Snajdrova (Novartis, CH) EMERGING TOPICS EFMC-ISMC SYMPOSIUM SECRETARIAT CRYOEM AS AN EMERGING TOOL FOR LATE BREAKING NEWS SMALLMOLECULE DRUG DISCOVERY Jean-Paul Renaud (RiboStruct, FR) LD ORGANISATION SPRL CONFIRMED PLENARY LECTURES Scientific Conference Producers EXPANDING CHEMICAL SPACE THROUGH AI LINKING Rue Michel de Ghelderode 33/2 SYNTHESIS PREDICTION AND AUTOMATION Phil BARAN 1348 Louvain-la-Neuve, Belgium Ola Engkvist (AstraZeneca, SE) Tel: +32 10 45 47 77 Fax: +32 10 45 97 19 (The Scripps Research Institute, US) Mail: [email protected] INNOVATIVE SYNTHESIS FOR MEDICINAL CHEMISTRY Karin BRINER Web: www.efmc-ismc.org Cristina Nevado (University of Zurich, CH) (Novartis, US) Jean-Paul CLOZEL NOVEL STRATEGIES AND METHODS FOR DRUG (Idorsia, CH) Organised by On behalf of DISCOVERY AND DEVELOPMENT (CPA Session) Stefan KNAPP Ke Ding (Jinan University, CN) (Goethe University Frankfurt, DE) PRODRUG STRATEGIES IN DRUG DESIGN AND DISCOVERY Bernd Clement (University of Kiel, DE) & Jarkko Rautio (University of Eastern Finland, FI) Visit www.efmc-ismc.org for online registration and abstract submission! Content Editorial 2 Corporate Members 4 EFMC Executive Committee 5 Council 6 Advisory Board 8 Influencing EU-Policy 9 EFMC Chemical Biology Initiative 10 Best Practices in Medicinal Chemistry 11 EFMC Communication Team / Young Scientists Network 12 EFMC-ASMC’19 – Report 14 EFMC-ACSMEDI MedChem Frontiers 2019 – Report 15 EFMC Photo Contest 2019 16 EFMC Awards 18 EFMC Prizes 20 EFMC-YMCS 2019 – Report 22 EFMC Short Course 2019 - Report 24 National Adhering Organisations 26 1 Editorial Dear colleagues, A REVIEW OF 2019 EFMC is a very active and diverse organisation, with 26 EFMC had a busy year in 2019, including two major events. national member societies, multiple international part- First was the biennial EFMC|ACSMEDI MedChem Frontiers, ners, scientific events and initiatives. It recently reviewed which took place on June 10-13, 2019 in the beauti- its strategy and agreed on future activities at a work- ful city of Krakow, Poland. This event was co-organized shop, in February 2019, reaffirming EFMC’s aspirations. I with ACS MEDI, to facilitate interactions between the am happy to report that we could implement many of European and American communities. It was hosted by the recommendations and proposals that came out of the Polish Society of Medicinal Chemistry, and attracted this workshop by the end of the year. This allowed for over 250 international participants. Then came the EFMC an improved focus, better processes, and some creative International Symposium on Advances in Synthetic and changes with regard to EFMC’s initiatives. Thanks to the Medicinal Chemistry (EFMC-ASMC’19), which is the forum involvement of many, we made significant progress in where organic and medicinal chemists meet, and which better integrating chemical biology, improving communi- gathered 600 participants in Athens on September 1-5, cation, and generating opportunities for young scientists. 2019. We are delighted that this 8th edition confirmed It is a great pleasure to serve a community so involved the success of this series, reaching more and more sci- and so dynamic. entists around the globe. The scientific programme de- fined by Varinder Aggarwal (University of Bristol, UK) & Before providing an overview of the most important Spiros Liras (Biogen, USA) was excellent. events of 2019 and of the rich range of activities planned by our Federation for 2020, I would like to thank Gabriele The EFMC Young Medicinal Chemist Symposium (EFMC- Costantino (Italy), Peter Molenveld (The Netherlands) and YMCS’19) immediately followed the EFMC-ASMC’19 meet- Franz Von Nussbaum (Germany) for their long-time con- ing in Athens. It was a pleasure to see the ever-increas- tribution to the EFMC Council. Their successors are Iwan ing number of young scientists taking part in this lively De Esch (The Netherlands), Anna K.H. Hirsh (Germany) meeting, with excellent scientific contributions and lots and Gianluca Sbardella (Italy), to whom I extend a warm of active networking. I am grateful to Manolis Fousteris welcome. (University of Patras, Greece), his committee and the EFMC Young Scientists Network for having put together I also thank the Executive Committee (EC) members for an interesting programme, and for creating perfect con- constant support and valuable advice. Special thanks go ditions for a dynamic exchange, which participants clear- to Rui Moreira, who accepted the position of President- ly appreciated. Elect and who will be my successor in 2021. I welcome Masterfully organised by Iwan De Esch and Henk Franz Von Nussbaum as new EC member, looking for- Timmerman, the 15th EFMC Short Course took place ward to a close collaboration. The other EC members end of April 2019 and focused on Fragment-based Drug are Anders Karlén (Secretary), Antoni Torrens (Treasurer), Discovery. This series will continue with a Course on New Matt Tozer and Luc Van Hijfte, with the support of Henk Opportunities in GPCR Drug Discovery, scheduled for Timmerman as EFMC Advisor. May 17-20, 2020 and organised by Gyorgy Keseru and Rob Finally, I am happy to announce our two new Corporate Leurs. Members: Galchimia & Mercachem-Syncom, which joined To learn more about the events, I invite you to read the the group of companies financially supporting EFMC, its full reports on pages 10 to 13 of this Yearbook. mission to advance the science of medicinal chemis- try and chemical biology, as well as activities for young The EFMC working groups provided valuable contribu- scientists. EFMC greatly appreciates the generosity and tions on EU policy, communication, chemical biology and commitment of all its Corporate Members. best practices. The active contribution of many partici- 2 | EFMC YEARBOOK 2020 pants is gratefully acknowledged. You will find the report Scientists Network has created a PhD Prize, to provide fi- of their activities on pages 10 to 13 of the Yearbook. nancial support for participation in EFMC-ISMC 2020. The calls for the awards and prizes are open until January 31, EFMC also has numerous scientific interactions with part- and I encourage everyone to submit nominations. ners around the world. It is worth mentioning that Antoni Torrens organised a session on “Exploring New Pathways EFMC is fully aware that medicinal chemistry is a con- to Tackle Immune-oncology” at the 2019 Medicinal stantly evolving discipline, part of a continuum that in- Chemistry Symposium of the Chinese Pharmaceutical cludes chemical biology. To recognise this fact and bal- Association (CMCS 2019). Koen Augustyns held a session ance its scientific offer, I am pleased to announce